David Arkowitz - 04 Jun 2021 Form 4 Insider Report for F-star Therapeutics, Inc. (FSTX)

Role
Director
Signature
/s/ Darlene Deptula-Hicks, Attorney-in-fact
Issuer symbol
FSTX
Transactions as of
04 Jun 2021
Transactions value $
$0
Form type
4
Filing time
07 Jun 2021, 16:03:48 UTC
Previous filing
04 Jun 2021
Next filing
08 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FSTX Stock Option Award $0 +20K $0.00 20K 04 Jun 2021 Common Stock 20K $6.88 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted under the Issuer's non-employee director compensation program.
F2 Shares under the award shall vest in 12 equal monthly installments over a one-year period through June 4, 2022, subject to the Reporting Person's continued service as a director of the company.